Delivery Order SPE2DP20D0002-SPE2DP24F1238
Award Date 12/14/23
Potential Completion Date 12/19/23
Potential Value $2.4M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Teva Pharmaceuticals USA, Inc. has been awarded a $1,526,969 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4 vaccine. This delivery order was issued under an existing contract vehicle and will support the immunization programs of the military. Teva will deliver the vaccine products to the agency's location in Parsippany, New Jersey by December 19, 2023. As a major pharmaceutical manufacturer, Teva has extensive experience...
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $564,707.52 firm fixed price delivery order to supply adenovirus type 4. The place of performance is Teva's facility in Parsippany, New Jersey. The delivery order has a period of performance from August 11, 2021 through August 24, 2021. No set aside designation or subcontractors were identified. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring and...
- Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The delivery order, issued on July 22, 2020, requires Teva Pharmaceuticals to deliver the requested pharmaceutical product to a location in Parsippany, New Jersey by July 28, 2020. No subcontractors or set aside designations were identified....
- Teva Pharmaceuticals USA, Inc. was awarded a $542,988 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The firm fixed price order calls for Teva to deliver the pharmaceutical product to a location in Parsippany, New Jersey between August 19 and 25, 2020. No subcontractors or set aside designations were identified. The Defense Logistics Agency Troop Support...
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals Usa, Inc. a $847,061 firm fixed price delivery order to supply adenovirus type 4. The place of performance is Teva's facility in Parsippany, New Jersey. The order period of performance is September 9, 2021 through September 28, 2021. No set aside designation or subcontractors are indicated. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals, medical supplies,...
- Teva Pharmaceuticals USA, Inc. has been awarded a firm fixed price delivery order valued at one hundred fifty-two thousand six hundred ninety-six dollars and eighty-eight cents ($152,696.88) by the Defense Logistics Agency Troop Support Medical to provide adenovirus type 4 vaccine. This delivery order was issued under an existing contract vehicle and will support immunization programs of the military. Teva Pharmaceuticals USA, Inc. is a manufacturer of pharmaceutical products located in...
- The Defense Logistics Agency awarded Teva Pharmaceuticals USA, Inc. a firm fixed-price delivery order valued at $165,156.93 for Adenovirus Type 4 vaccine with an ultimate completion date of September 23, 2025. The contract, issued without a set-aside designation, is being performed in Parsippany, New Jersey, where Teva maintains its U.S. headquarters. This delivery order supports the Department of Defense's immunization programs and represents part of Teva's established role as a critical...
- Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The delivery order, issued on December 7, 2020, calls for Teva to supply the viral product to a location in Parsippany, New Jersey, with completion required by December 15, 2020. No subcontractors or set-aside designations were identified. The...
- Teva Pharmaceuticals USA, Inc. was awarded a Firm Fixed Price Delivery Order by the Defense Logistics Agency Troop Support Medical to provide Adenovirus Type 4 vaccine in Parsippany, New Jersey. The contract has a potential value of $146,823.93 and a completion date of December 20, 2022. Teva is a foreign-owned, for-profit manufacturer that has a history of providing pharmaceutical products, including vaccines and respiratory treatments, to various federal customers such as the Department of...
- Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The prime contractor will deliver the requested pharmaceutical products to the place of performance in Parsippany, New Jersey by September 29, 2020 in support of DLA's medical supply chain initiatives. No subcontractors or set aside designations were indicated. DLA manages the Department of Defense's global logistics...